Overview
- A 43‑year‑old man from Ramanattukara was admitted to Kozhikode Medical College and remains on ventilator support after testing positive for Nipah; he received a monoclonal antibody on June 12 and remdesivir was administered on June 14.
- The Indian Council of Medical Research has deployed a team to Kozhikode and the National Centre for Disease Control experts are expected to join, while household surveys and active surveillance have visited hundreds of local homes.
- Officials have compiled a contact list of roughly 100–103 people with four classed as very high risk and multiple close contacts testing negative so far, and no secondary Nipah cases have been reported.
- Treatment logistics revealed gaps: ribavirin was given on admission, remdesivir had to be procured from Bahrain after Indian supplies were unavailable, and an expired antiviral stock was found in Chennai.
- The response is taking place against Kerala’s history of recurring bat‑linked Nipah spillovers and a separate rise in shigellosis that has produced about 135 cases statewide, a strain that has fuelled political criticism over coordination and a contested DHS transfer.